Good decisions require good information
Find hidden gems and smart strategies from top experts when you join Seeking Alpha.
MBOT Microbot Medical Inc.Stock Price & Overview
$1.07
Charts
Quant Ranking
MBOT Analysis
MBOT News
Latest Headlines
Ratings Summary
People Also Follow
Similar to MBOT
ETFs Holding MBOT
MBOT Company Profile
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
MBOT Revenue
MBOT Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Profitability
Momentum
Capital Structure
Dividends
MBOT Ownership
MBOT Peers
Risk
Technicals
MBOT Transcripts
Investor Presentations
MBOT SEC Filings
Press Releases
MBOT Income Statement
MBOT Balance Sheet
MBOT Cash Flow Statement
MBOT Long Term Solvency
Discover More
You may be interested in: